Lupin dispatches generic rheumatoid arthritis drug in US market

Lupin dispatches generic rheumatoid arthritis drug in US market

Overview

  • Post By : Kumar Jeetendra

  • Source: PTI

  • Date: 02 Sep,2020

Medicine manufacturer Lupin on Wednesday said it has established Leflunomide pills, used to treat rheumatoid arthritis, even in the US marketplace.

The business has established the product in 10 mg and 20 mg strengths after receiving the approval by the US Food and Drug Administration (USFDA) before, Lupin said in a statement.

The item could be manufactured in drug manufacturer’s Pithampur (Unit I) centre in Madhya Pradesh, it included.

The Mumbai-based firm’s product is the generic equivalent of Sanofi-Aventis US LLC’s Arava tablets and is used for the treatment of adults who have active rheumatoid arthritis (RA).

According to IQVIA MAT June statistics, Leflunomide pills had an yearly sales of approximately USD 42 million at the united states.

About Author